The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

Plasma p-tau217 immunoassay offers accurate detection of Alzheimer’s disease pathology, supporting early diagnosis and ...

A trial to identify fast and accurate blood tests that can diagnose dementia comes at an "exciting" time in the treatment of ...

Seoul Asan Medical Center said it started prescribing the early Alzheimer's ... disease to the early stages of dementia. The ...

KisunlaTM (donanemab-azbt) , pronounced kih-SUHN-lah, is used to treat adults with early symptomatic Alzheimer's disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of ...

Kisunla was first approved in the United States in July 2024, approved in Japan in September 2024 and then in Great Britain in October 2024 "Bringing Alzheimer's disease treatment options to the ...

If a cancer diagnosis is given, PET scans may be recommended throughout treatment to see if treatment is working and to assess the likely outcome of the disease. After cancer treatment, PET scans can ...

Research from a UMass-Lowell team found that Alzheimer’s patients had certain concentrations of common elements in their ...

The Company has successfully dosed the first patient with moderate Alzheimer's disease using intranasal foralumab at Brigham and Women’s Hospital in Boston, Massachusetts following on from their ...

Massachusetts following on from their baseline PET scan. Alzheimer’s disease represents an almost insurmountable global health challenge, affecting millions worldwide with few treatment options ...